Qube Research & Technologies (QRT)’s Mersana Therapeutics MRSN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-6,115
Closed -$45.3K 3884
2025
Q2
$45.3K Sell
6,115
-40,869
-87% -$359K ﹤0.01% 3164
2025
Q1
$404K Buy
46,984
+33,087
+238% +$511K ﹤0.01% 2624
2024
Q4
$497K Sell
13,897
-21,185
-60% -$1.1M ﹤0.01% 2479
2024
Q3
$1.66M Sell
35,082
-4,621
-12% -$204K ﹤0.01% 1827
2024
Q2
$2M Buy
39,703
+1,315
+3% +$95.1K ﹤0.01% 1626
2024
Q1
$4.3M Buy
+38,388
New +$3.82M 0.01% 1325
2023
Q3
Sell
-8,164
Closed -$672K 4253
2023
Q2
$672K Sell
8,164
-1,908
-19% -$279K ﹤0.01% 1438
2023
Q1
$1.03M Buy
10,072
+6,617
+192% +$929K 0.01% 1278
2022
Q4
$506K Buy
3,455
+1,251
+57% +$211K ﹤0.01% 1469
2022
Q3
$372K Buy
2,204
+1,279
+138% +$208K ﹤0.01% 1562
2022
Q2
$107K Sell
925
-11,053
-92% -$1.04M ﹤0.01% 1928
2022
Q1
$1.2M Buy
11,978
+9,668
+419% +$1.13M 0.01% 1075
2021
Q4
$359K Buy
+2,310
New +$449K ﹤0.01% 1713
2021
Q3
Sell
-2,507
Closed -$851K 2571
2021
Q2
$851K Buy
+2,507
New +$949K 0.01% 1015

Other funds holding MRSN